AFT PHARMACEUTICALS LIMITED

AFP ASX

AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. Its feature brands include Crystaderm, Maxigesic, Coco-Scalp, Maxiclear, Eyecare Hub, and Allergy Hub. It operates through the following geographical segments: Australia, New Zealand, Southeast Asia, and Rest of the World. The Australia segment caters to the Australian market. The New Zealand segment focuses in the head office function, supplier relationships and procurement of stock, and regulatory, marketing, and finance activities of the group. The Southeast Asia segment relates in the sales activities in Brunei, Hong Kong, Malaysia, Philippines, Singapore and Vietnam markets. The Rest of the World segment comprises of out licensing of internet protocol developments to markets in which the firm does not have a presence and the export of products to export markets. The company was founded by Hartley and Marree Atkinson on September 4, 1997 and is headquartered in Auckland, New Zealand.